# EVIDENT (Evidence-Based Validation & Innovation for Rapid Therapeutics)

Canonical: https://abierto.us/opportunities/122aec725a09476e87b7cad91afe79ee

- Notice type: Special notice
- Status: Closed. Deadline was December 5, 2025 at 5:00 PM EST
- Department: Department of Health and Human Services
- Agency: National Institutes of Health
- Contracting office: Advanced Research Projects Agency for Health (Arpa-H) (75N992)
- NAICS: 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Product or service code: AN13 Health R&D Services; Health Care Services; Experimental Development
- First posted: November 25, 2025
- Last posted: November 25, 2025
- SAM.gov: https://sam.gov/workspace/contract/opp/122aec725a09476e87b7cad91afe79ee/view

## Description

The Advanced Research Projects Agency for Health (ARPA-H) is launching the Evidence-Based Validation & Innovation for Rapid Therapeutics in Behavioral Health (EVIDENT) initative as a method to efficiently fund innovative solutions in support of HHS and ARPA-H objectives. In Partnership with ATI, ARPA-H is hosting a Proposers’ Day in support of the EVIDENT Technical Areas. Proposers’ Day is scheduled for Dec 10, 2025. The hybrid event will be held in-person in Arlington, VA and virtually. Please see links for additional information and registration details.

## Publications

- November 25, 2025: Special notice, due December 5, 2025 at 5:00 PM EST. Notice 122aec725a09476e87b7cad91afe79ee. https://sam.gov/workspace/contract/opp/122aec725a09476e87b7cad91afe79ee/view

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/122aec725a09476e87b7cad91afe79ee.